AncientAyurved.co.in

Parapalegia indicates paralysis of both lower extremities. This may occur in diseases of spinal cord, spinal roots peripheral nerves or may be hysterical. If the onset is acute, it may be difficult to distinguish spinal from neuropathic paralysis because the element of spinal shock may result in abolition of reflexes and flacidity.

Walking disability due to the drawing up (contractions) of Kandara (muscle tendon) of one leg by deranged Vayu situated at Kati (lumbosacral) region is the main symptom of Khanja (Monoplegia) and when both legs are similarly affected the disease is called Pangu (Parplegia). It originates at Kati due to the vitiated Vata, (a humor) probably the Katyasrita Vata, that is, Apanavayu is involved. The main complaints are disturbed visceral reflexes (micturition and defection), loss of sensation, inability to walk due to Apanavaigunya. The definition of Vata itself explains that the normal function of Vata is the regulation of motor and sensory functions. Therefore, vitiation of Vata leading to the onset of a disease usually manifests as an impairment of these functions.

The Ayurvedic physicians have been able to manage this condition with a series of measures and therapies under Panchakarma. An attempt has been made to evaluate following six requirements of treatment of Ayurvedic drugs on patients.

Drug/ Regime	No.of patients
i)Schacharadi Yoga and Sodhana	60
ii)Comparative study of the effects of Sahacharadi Tailam, Nirgundi Tailam & Bhadradarvadi Tailam in Sodhana and Samanatherapies	20
iii) Effects of Prabhajan Vimardanam Tailam in Sodhana & Samana therapies	58
iv) The role of Ayurvedic drugs and physiotherapy in the management of Pangu	54
v)  Action of Asvagandha Churna & Gorochanadi Vati internal and Balashvagandhalakshati Tailam external in Khanja and Pangu	32
vi)   A comparative study of certain Ayurvedic formulations and Panchakarma therapy in the management of Pangu	20

The diagnosis of the patients has been made on the basis of clinical, radiological findings and other necessary laboratoryinvestigations. A numerical score of various clinical features and laboratory investigators was developed and applied for assessment of efficacy of therapeutic regimen.
Conclusion
The clinical trials revealed that these regimens were found to be effective in management of paraplegia. The results were encouraging and statistically significant. On comparison of results obtained with different studies i.e. 4th study with Sahacharadi group was found to be the most effective and this encouraging result was observed in the Sahachara group also of the fifth study.

In order to confirm the therapeutic potentialities of Sahachara and to find out the mechanism of action of this drug detailed pharmacological studies were undertaken and the results obtained confirm its clinical claims in the management of paraplegia. The results obtained with Nirgundi group in the fifth study was also encouraging and hence this drug was also taken up for the pharmacological studies. The results obtained were found to support the clinical finding

source  http://ccras.nic.in/Research_Actvities/20081015_parapleg.htm

This post has been viewed 64 times.